FLOT2 overexpression is reported to be associated with the tumor grade, TNM stage, distant metastasis in multiple malignancies and can be useful as a prognostic biomarker for breast cancer progression (Liu et al. 2018; Wang et al. 2013). This evidence concerns the gene FLOT2 and neoplasm.